Analytical Data
-
基因名
RNF7
- Application
-
种属
Human
-
表达系统
E. coli
-
标签
N-GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UBF6-1
-
表达区间
A2-K113
-
蛋白长度
Full Length of Isoform-1 Mature Protein
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EsxB, a protein component of the Esx secretion system, is a crucial element in the study of mycobacterial biology, particularly in Mycobacterium tuberculosis, the causative agent of tuberculosis. The Esx system, also known as the Type VII secretion system, plays a significant role in the pathogenesis of mycobacteria, facilitating the export of effector proteins that modulate host immune responses and contribute to bacterial survival within macrophages. The understanding of EsxB and its interactions has gained importance in recent years, as it is implicated in host-pathogen interactions and may influence disease progression. Researchers have focused on the structural and functional characterization of EsxB to elucidate its role in virulence and immune evasion. Insights into the mechanisms by which EsxB and its related proteins operate not only enhance our understanding of mycobacterial pathogenesis but also hold potential for developing novel therapeutic strategies and vaccines. Overall, EsxB represents a significant target for understanding the complex interplay between Mycobacterium tuberculosis and the host immune system, paving the way for innovations in tuberculosis treatment and prevention.
